Skip to main content
SpringerLink
Log in

Magnetic Resonance Imaging in Prostate Cancer

  • Chapter
  • First Online:
Robot-Assisted Radical Prostatectomy

  • 465 Accesses

Abstract

Multiparametric MRI of the prostate has become the standard imaging modality in the work-up of men with suspected or proven prostate cancer. Multiparametric MRI has gained a prominent role in the novel image-based diagnostic pathway, allowing the avoidance of unnecessary prostate biopsy, reducing the detection of clinically insignificant and increasing that of clinically significant disease, and enabling a targeted image-directed prostate sampling. Moreover, multiparametric MRI has also shown utility as a tool for local staging in adjunct to conventional clinical parameters and nomograms, for treatment planning in men scheduled for radical prostatectomy, radiation therapy and focal therapy, and for disease monitoring in those men on active surveillance or with biochemical recurrence after radical treatment with curative intent. This chapter will cover the basics of multiparametric prostate MRI scoring and reporting, and its main clinical applications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Steyn JH, Smith FW. Nuclear magnetic resonance imaging of the prostate. Br J Urol. 1982;54(6):726–8.

    Article  CAS  PubMed  Google Scholar 

  2. Giganti F, Rosenkrantz AB, Villeirs G, Panebianco V, Stabile A, Emberton M, et al. The evolution of MRI of the prostate: the past, the present, and the future. Am J Roentgenol. 2019;213(2):384–96.

    Article  Google Scholar 

  3. Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol. 2011;59(4):477–94.

    Article  PubMed  Google Scholar 

  4. Mottet N, Bellmunt J, Briers E, Bolla M, Bourke, Cornford P, et al. EAU-ESTRO-ESUR-SIOG guidelines on prostate cancer. Edn. presented at the EAU annual congress Amsterdam 2020. Arnhem: EAU Guidelines Office; 2020.

    Google Scholar 

  5. Van Poppel H, Hogenhout R, Albers P, van den Bergh RCN, Barentsz JO, Roobol MJ. Early detection of prostate cancer in 2020 and beyond: facts and recommendations for the European Union and the European Commission. Eur Urol. 2021;79(3):327–9.

    Article  PubMed  Google Scholar 

  6. Panebianco V, Barchetti G, Simone G, Del Monte M, Ciardi A, Grompone MD, et al. Negative multiparametric magnetic resonance imaging for prostate cancer: what’s next? Eur Urol. 2018;74(1):48–54.

    Article  PubMed  Google Scholar 

  7. Sathianathen NJ, Omer A, Harriss E, Davies L, Kasivisvanathan V, Punwani S, et al. Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data system era: a systematic review and meta-analysis. Eur Urol. 2020;78(3):402–14.

    Article  PubMed  Google Scholar 

  8. Padhani AR, Weinreb J, Rosenkrantz AB, Villeirs G, Turkbey B, Barentsz J. Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 status update and future directions. Eur Urol. 2019;75(3):385–96.

    Article  PubMed  Google Scholar 

  9. Margolis DJA. Multiparametric MRI for localized prostate cancer: lesion detection and staging. Biomed Res Int. 2014;2014:1–11.

    Article  Google Scholar 

  10. Meyer H-J, Wienke A, Surov A. Discrimination between clinical significant and insignificant prostate cancer with apparent diffusion coefficient—a systematic review and meta analysis. BMC Cancer. 2020;20(1):482.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Panebianco V, Giganti F, Kitzing YX, Cornud F, Campa R, De Rubeis G, et al. An update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines. Insights Imaging. 2018;9(1):87–101.

    Article  PubMed  Google Scholar 

  12. Wei C, Jin B, Szewczyk-Bieda M, Gandy S, Lang S, Zhang Y, et al. Quantitative parameters in dynamic contrast-enhanced magnetic resonance imaging for the detection and characterization of prostate cancer. Oncotarget. 2018;9(22):15997–6007.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Schoots IG, Barentsz JO, Bittencourt LK, Haider MA, Macura KJ, Margolis DJA, et al. PI-RADS Committee position on MRI without contrast medium in biopsy-naive men with suspected prostate cancer: narrative review. Am J Roentgenol. 2021;216(1):3–19.

    Article  Google Scholar 

  14. Zawaideh JP, Sala E, Shaida N, Koo B, Warren AY, Carmisciano L, et al. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice. Eur Radiol. 2020;30(7):4039–49.

    Article  CAS  PubMed  Google Scholar 

  15. Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol. 2019;76(3):340–51.

    Article  PubMed  Google Scholar 

  16. Panebianco V, Barchetti F, Barentsz J, Ciardi A, Cornud F, Futterer J, et al. Pitfalls in interpreting mp-MRI of the prostate: a pictorial review with pathologic correlation. Insights Imaging. 2015;6(6):611–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Wang X, Liu W, Lei Y, Wu G, Lin F. Assessment of prostate imaging reporting and data system version 2.1 false-positive category 4 and 5 lesions in clinically significant prostate cancer. Abdom Radiol (NY). 2021;46(7):3410–7. https://doi.org/10.1007/s00261-021-03023-w.

    Article  PubMed  Google Scholar 

  18. Thomas S, Oto A. Multiparametric MR imaging of the prostate. Radiol Clin North Am. 2018;56(2):277–87.

    Article  PubMed  Google Scholar 

  19. Labra WA, Zúñiga GÁ. Pitfalls en RM de Próstata Multiparamétrica. Rev Chil Radiol. 2019;25(4):128–40.

    Google Scholar 

  20. Woo S, Suh CH, Kim SY, Cho JY, Kim SH. Diagnostic performance of prostate imaging reporting and data system version 2 for detection of prostate cancer: a systematic review and diagnostic meta-analysis. Eur Urol. 2017;72(2):177–88.

    Article  PubMed  Google Scholar 

  21. Kang Z, Min X, Weinreb J, Li Q, Feng Z, Wang L. Abbreviated biparametric versus standard multiparametric MRI for diagnosis of prostate cancer: a systematic review and meta-analysis. Am J Roentgenol. 2019;212(2):357–65.

    Article  Google Scholar 

  22. Alabousi M, Salameh J-P, Gusenbauer K, Samoilov L, Jafri A, Yu H, et al. Biparametric vs multiparametric prostate magnetic resonance imaging for the detection of prostate cancer in treatment-naïve patients: a diagnostic test accuracy systematic review and meta-analysis. BJU Int. 2019;124(2):209–20.

    Article  PubMed  Google Scholar 

  23. Schoots IG, Barentsz JO, Bittencourt LK, Haider MA, Macura KJ, Margolis DJA, et al. PI-RADS Committee position on MRI without contrast medium in biopsy naive men with suspected prostate cancer: a narrative review. Am J Roentgenol. 2021;216(1):3–19.

    Article  Google Scholar 

  24. Giganti F, Allen C, Emberton M, Moore CM, Kasivisvanathan V. Prostate imaging quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial. Eur Urol Oncol. 2020;3(5):615–9.

    Article  PubMed  Google Scholar 

  25. de Rooij M, Israël B, Tummers M, Ahmed HU, Barrett T, Giganti F, et al. ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists’ training. Eur Radiol. 2020;30(10):5404–16. https://doi.org/10.1007/s00330-020-06929-z.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Panebianco V, Pecoraro M, Fiscon G, Paci P, Farina L, Catalano C. Prostate cancer screening research can benefit from network medicine: an emerging awareness. npj Syst Biol Appl. 2020;6(1):13.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Eldred-Evans D, Burak P, Connor MJ, Day E, Evans M, Fiorentino F, et al. Population-based prostate cancer screening with magnetic resonance imaging or ultrasonography: the IP1-PROSTAGRAM study. JAMA Oncol. 2021;7(3):395–402. https://jamanetwork.com/journals/jamaoncology/fullarticle/2776224.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Da Silva V, Cagiannos I, Lavallée LT, Mallick R, Witiuk K, Cnossen S, et al. An assessment of Prostate Cancer Research International: Active Surveillance (PRIAS) criteria for active surveillance of clinically low-risk prostate cancer patients. CUAJ. 2017;11(8):238–43.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Drost F-JH, Osses DF, Nieboer D, Steyerberg EW, Bangma CH, Roobol MJ, et al. Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev. 2019;4(4):CD012663. https://doi.org/10.1002/14651858.CD012663.pub2.

    Article  PubMed  Google Scholar 

  30. Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018;378(19):1767–77.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Rouvière O, Puech P, Renard-Penna R, Claudon M, Roy C, Mège-Lechevallier F, et al. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol. 2019;20(1):100–9.

    Article  PubMed  Google Scholar 

  32. van der Leest M, Cornel E, Israël B, Hendriks R, Padhani AR, Hoogenboom M, et al. Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: a large prospective multicenter clinical study. Eur Urol. 2019;75(4):570–8.

    Article  PubMed  Google Scholar 

  33. Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389(10071):815–22.

    Article  PubMed  Google Scholar 

  34. Kasivisvanathan V, Stabile A, Neves JB, Giganti F, Valerio M, Shanmugabavan Y, et al. Magnetic resonance imaging-targeted biopsy versus systematic biopsy in the detection of prostate cancer: a systematic review and meta-analysis. Eur Urol. 2019;76(3):284–303.

    Article  PubMed  Google Scholar 

  35. Caglic I, Kovac V, Barrett T. Multiparametric MRI—local staging of prostate cancer and beyond. Radiol Oncol. 2019;53(2):159–70.

    Article  PubMed  PubMed Central  Google Scholar 

  36. de Rooij M, Hamoen EHJ, Witjes JA, Barentsz JO, Rovers MM. Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis. Eur Urol. 2016;70(2):233–45.

    Article  PubMed  Google Scholar 

  37. Marenco J, Orczyk C, Collins T, Moore C, Emberton M. Role of MRI in planning radical prostatectomy: what is the added value? World J Urol. 2019;37(7):1289–92.

    Article  PubMed  Google Scholar 

  38. Duvnjak P, Schulman AA, Holtz JN, Huang J, Polascik TJ, Gupta RT. Multiparametric prostate MR imaging: impact on clinical staging and decision making. Radiol Clin North Am. 2018;56(2):239–50.

    Article  PubMed  Google Scholar 

  39. Schiavina R, Bianchi L, Borghesi M, Dababneh H, Chessa F, Pultrone CV, et al. MRI displays the prostatic cancer anatomy and improves the bundles management before robot-assisted radical prostatectomy. J Endourol. 2018;32(4):315–21.

    Article  PubMed  Google Scholar 

  40. Radtke JP, Hadaschik BA, Wolf MB, Freitag MT, Schwab C, Alt C, et al. The impact of magnetic resonance imaging on prediction of extraprostatic extension and prostatectomy outcome in patients with low-, intermediate- and high-risk prostate cancer: try to find a standard. J Endourol. 2015;29(12):1396–405.

    Article  PubMed  Google Scholar 

  41. Karzai F, Walker SM, Wilkinson S, Madan RA, Shih JH, Merino MJ, et al. Sequential prostate magnetic resonance imaging in newly diagnosed high-risk prostate cancer treated with neoadjuvant enzalutamide is predictive of therapeutic response. Clin Cancer Res. 2021;27(2):429–37.

    Article  CAS  PubMed  Google Scholar 

  42. Fennessy FM, Fedorov A, Vangel MG, Mulkern RV, Tretiakova M, Lis RT, et al. Multiparametric MRI as a biomarker of response to neoadjuvant therapy for localized prostate cancer—a pilot study. Acad Radiol. 2020;27(10):1432–9.

    Article  PubMed  Google Scholar 

  43. Schoots IG, Petrides N, Giganti F, Bokhorst LP, Rannikko A, Klotz L, et al. Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review. Eur Urol. 2015;67(4):627–36.

    Article  PubMed  Google Scholar 

  44. Lam TBL, MacLennan S, Willemse P-PM, Mason MD, Plass K, Shepherd R, et al. EAU-EANM-ESTRO-ESUR-SIOG prostate cancer guideline panel consensus statements for deferred treatment with curative intent for localised prostate cancer from an international collaborative study (DETECTIVE study). Eur Urol. 2019;76(6):790–813.

    Article  PubMed  Google Scholar 

  45. Schoots IG, Nieboer D, Giganti F, Moore CM, Bangma CH, Roobol MJ. Is magnetic resonance imaging-targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low-risk prostate cancer? A systematic review and meta-analysis. BJU Int. 2018;122(6):946–58.

    Article  PubMed  Google Scholar 

  46. Schoots IG, Moore CM, Rouvière O. Role of MRI in low-risk prostate cancer: finding the wolf in sheep’s clothing or the sheep in wolf’s clothing? Curr Opin Urol. 2017;27(3):238–45.

    Article  PubMed  Google Scholar 

  47. Klotz L, Loblaw A, Sugar L, Moussa M, Berman DM, Van der Kwast T, et al. Active surveillance magnetic resonance imaging study (ASIST): results of a randomized multicenter prospective trial. Eur Urol. 2019;75(2):300–9.

    Article  PubMed  Google Scholar 

  48. Moore CM, Giganti F, Albertsen P, Allen C, Bangma C, Briganti A, et al. Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations—a report of a European School of Oncology Task Force. Eur Urol. 2017;71(4):648–55.

    Article  PubMed  Google Scholar 

  49. Giganti F, Pecoraro M, Fierro D, Campa R, Del Giudice F, Punwani S, et al. DWI and PRECISE criteria in men on active surveillance for prostate cancer: a multicentre preliminary experience of different ADC calculations. Magn Reson Imaging. 2020;67:50–8.

    Article  PubMed  Google Scholar 

  50. Morgan VA, Riches SF, Giles S, Dearnaley D, deSouza NM. Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapy. Am J Roentgenol. 2012;198(3):596–602.

    Article  Google Scholar 

  51. Barchetti F, Panebianco V. Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy. Biomed Res Int. 2014;2014:1–23.

    Google Scholar 

  52. Casciani E, Polettini E, Carmenini E, Floriani I, Masselli G, Bertini L, et al. Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. Am J Roentgenol. 2008;190(5):1187–92.

    Article  Google Scholar 

  53. Roy C, Foudi F, Charton J, Jung M, Lang H, Saussine C, et al. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy. Am J Roentgenol. 2013;200(4):W361–8.

    Article  Google Scholar 

  54. Dinis Fernandes C, Dinh CV, Walraven I, Heijmink SW, Smolic M, van Griethuysen JJM, et al. Biochemical recurrence prediction after radiotherapy for prostate cancer with T2w magnetic resonance imaging radiomic features. Phys Imaging Radiat Oncol. 2018;7:9–15.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Abd-Alazeez M, Ramachandran N, Dikaios N, Ahmed HU, Emberton M, Kirkham A, et al. Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images. Prostate Cancer Prostatic Dis. 2015;18(2):128–36.

    Article  CAS  PubMed  Google Scholar 

  56. Notley M, Yu J, Fulcher AS, Turner MA, Cockrell CH, Nguyen D. Diagnosis of recurrent prostate cancer and its mimics at multiparametric prostate MRI. Br J Radiol. 2015;88(1054):20150362.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Panebianco V, Barchetti F, Sciarra A, Musio D, Forte V, Gentile V, et al. Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging. Eur Radiol. 2013;23(6):1745–52.

    Article  PubMed  Google Scholar 

  58. Maurer T, Eiber M, Fanti S, Budäus L, Panebianco V. Imaging for prostate cancer recurrence. Eur Urol Focus. 2016;2(2):139–50.

    Article  PubMed  Google Scholar 

  59. De Visschere PJL, Standaert C, Fütterer JJ, Villeirs GM, Panebianco V, Walz J, et al. A systematic review on the role of imaging in early recurrent prostate cancer. Eur Urol Oncol. 2019;2(1):47–76.

    Article  PubMed  Google Scholar 

  60. Panebianco V, Villeirs G, Weinreb JC, Turkbey BI, Margolis DJ, Richenberg J, et al. Prostate magnetic resonance imaging for local recurrence reporting (PI-RR): international consensus-based guidelines on multiparametric magnetic resonance imaging for prostate cancer recurrence after radiation therapy and radical prostatectomy. Eur Urol Oncol. 2021;4(6):868–76.

    Article  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Gianluca Giannarini and Valeria Panebianco are joint senior authorship.

Authors and Affiliations

  1. Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Rome, Italy

    Martina Pecoraro, Emanuele Messina, Giorgia Carnicelli & Valeria Panebianco

  2. Urology Unit, “Santa Maria della Misericordia” University Hospital, Udine, Italy

    Claudio Valotto & Gianluca Giannarini

  3. Urologic Section, Department of Human and Pediatric Pathology “Gaetano Barresi”, University of Messina, Messina, Italy

    Vincenzo Ficarra

Authors
  1. Martina Pecoraro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emanuele Messina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giorgia Carnicelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Claudio Valotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vincenzo Ficarra
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gianluca Giannarini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Valeria Panebianco
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Changzheng Hospital, Shanghai, China

    Shancheng Ren

  2. Institute of Urology, University College London, London, UK

    Senthil Nathan

  3. Urology Clinic, Medical, Surgical and Health Sciences Department, University of Trieste, Trieste, Italy

    Nicola Pavan

  4. The First affiliated Hospital of Guangzhou Medical University, Guangzhou, China

    Di Gu

  5. Urology, University College London Hospital NHS Trust, Hatfield, UK

    Ashwin Sridhar

  6. Department of Urology, Rush University Medical Center, Chicago, IL, USA

    Riccardo Autorino

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pecoraro, M. et al. (2022). Magnetic Resonance Imaging in Prostate Cancer. In: Ren, S., Nathan, S., Pavan, N., Gu, D., Sridhar, A., Autorino, R. (eds) Robot-Assisted Radical Prostatectomy. Springer, Cham. https://doi.org/10.1007/978-3-031-05855-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-05855-4_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-05854-7

  • Online ISBN: 978-3-031-05855-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation